Showing 1 - 4 results of 4 for search 'Bengt Hoepken', query time: 0.02s Refine Results
  1. 1
    Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis

    Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with... by Martin Rudwaleit, Pedro M. Machado, Vanessa Taieb, Natasha de Peyrecave, Bengt Hoepken, Lianne S. Gensler

    Published 2023-08-01
    Get full text
    Article
  2. 2
    Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol

    Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol by Walter P. Maksymowych, Thomas Kumke, Simone E. Auteri, Bengt Hoepken, Lars Bauer, Martin Rudwaleit

    Published 2021-10-01
    Get full text
    Article
  3. 3
    Certolizumab Pegol Efficacy in Patients With Non‐Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C‐Reactive Protein Status: An Analysis From the C‐axSpAnd Study

    Certolizumab Pegol Efficacy in Patients With Non‐Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C‐Reactive Protein Status: An Analysis From the C‐axSpAnd Study... by Philip C. Robinson, Walter P. Maksymowych, Lianne S. Gensler, Stephen Hall, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Natasha dePeyrecave, Atul Deodhar

    Published 2022-09-01
    Get full text
    Article
  4. 4
    Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study

    Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd s... by Robert Landewé, Désirée van der Heijde, Atul Deodhar, Martin Rudwaleit, Lianne S Gensler, Walter P Maksymowych, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri

    Published 2022-03-01
    Get full text
    Article

Search Tools: